Abstract
Hepatic steatosis (fatty liver) is increasingly recognized as a major component of the metabolic (insulin resistance) syndrome. It can progress to cirrhosis and hepatocellular carcinoma, leading to liver-related mortality. Increasing evidence shows a significant association between hepatic steatosis and hypertension; both are linked to the metabolic syndrome. This review discusses the evidence to support this association, and reviews the diagnosis and management of hepatic steatosis.
| Original language | English |
|---|---|
| Pages (from-to) | 182-7 |
| Number of pages | 6 |
| Journal | Current hypertension reports |
| Volume | 10 |
| Issue number | 3 |
| Publication status | Published - 1 Jun 2008 |